• Definium Therapeutics issued inducement stock options covering 45,940 common shares to two newly hired non-executive employees.
• Grants carry effective dates of Oct. 13, 2026.
• Award terms set 25% vesting on the first anniversary.
• Remaining 75% vests in substantially equal monthly increments over the following three years, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610131601BIZWIRE_USPR_____20261013_BW044419) on October 13, 2026, and is solely responsible for the information contained therein.